Metabolic Disease Drugs Market, Global Outlook and Forecast 2023-2028

Report ID: 1648024 | Published Date: Jan 2025 | No. of Page: 63 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Metabolic Disease Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Metabolic Disease Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Metabolic Disease Drugs Overall Market Size
    2.1 Global Metabolic Disease Drugs Market Size: 2021 VS 2028
    2.2 Global Metabolic Disease Drugs Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Metabolic Disease Drugs Players in Global Market
    3.2 Top Global Metabolic Disease Drugs Companies Ranked by Revenue
    3.3 Global Metabolic Disease Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Metabolic Disease Drugs Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Metabolic Disease Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Metabolic Disease Drugs Players in Global Market
        3.6.1 List of Global Tier 1 Metabolic Disease Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 Metabolic Disease Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Metabolic Disease Drugs Market Size Markets, 2021 & 2028
        4.1.2 Glycogen Metabolism Disease Drug
        4.1.3 Lipid Metabolism Disease Drug
        4.1.4 Amino Acid Metabolism Drug
        4.1.5 Other
    4.2 By Type - Global Metabolic Disease Drugs Revenue & Forecasts
        4.2.1 By Type - Global Metabolic Disease Drugs Revenue, 2017-2022
        4.2.2 By Type - Global Metabolic Disease Drugs Revenue, 2023-2028
        4.2.3 By Type - Global Metabolic Disease Drugs Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Metabolic Disease Drugs Market Size, 2021 & 2028
        5.1.2 Hospital Pharmacy
        5.1.3 Retail Pharmacy
    5.2 By Application - Global Metabolic Disease Drugs Revenue & Forecasts
        5.2.1 By Application - Global Metabolic Disease Drugs Revenue, 2017-2022
        5.2.2 By Application - Global Metabolic Disease Drugs Revenue, 2023-2028
        5.2.3 By Application - Global Metabolic Disease Drugs Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Metabolic Disease Drugs Market Size, 2021 & 2028
    6.2 By Region - Global Metabolic Disease Drugs Revenue & Forecasts
        6.2.1 By Region - Global Metabolic Disease Drugs Revenue, 2017-2022
        6.2.2 By Region - Global Metabolic Disease Drugs Revenue, 2023-2028
        6.2.3 By Region - Global Metabolic Disease Drugs Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Metabolic Disease Drugs Revenue, 2017-2028
        6.3.2 US Metabolic Disease Drugs Market Size, 2017-2028
        6.3.3 Canada Metabolic Disease Drugs Market Size, 2017-2028
        6.3.4 Mexico Metabolic Disease Drugs Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Metabolic Disease Drugs Revenue, 2017-2028
        6.4.2 Germany Metabolic Disease Drugs Market Size, 2017-2028
        6.4.3 France Metabolic Disease Drugs Market Size, 2017-2028
        6.4.4 U.K. Metabolic Disease Drugs Market Size, 2017-2028
        6.4.5 Italy Metabolic Disease Drugs Market Size, 2017-2028
        6.4.6 Russia Metabolic Disease Drugs Market Size, 2017-2028
        6.4.7 Nordic Countries Metabolic Disease Drugs Market Size, 2017-2028
        6.4.8 Benelux Metabolic Disease Drugs Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Metabolic Disease Drugs Revenue, 2017-2028
        6.5.2 China Metabolic Disease Drugs Market Size, 2017-2028
        6.5.3 Japan Metabolic Disease Drugs Market Size, 2017-2028
        6.5.4 South Korea Metabolic Disease Drugs Market Size, 2017-2028
        6.5.5 Southeast Asia Metabolic Disease Drugs Market Size, 2017-2028
        6.5.6 India Metabolic Disease Drugs Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Metabolic Disease Drugs Revenue, 2017-2028
        6.6.2 Brazil Metabolic Disease Drugs Market Size, 2017-2028
        6.6.3 Argentina Metabolic Disease Drugs Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Metabolic Disease Drugs Revenue, 2017-2028
        6.7.2 Turkey Metabolic Disease Drugs Market Size, 2017-2028
        6.7.3 Israel Metabolic Disease Drugs Market Size, 2017-2028
        6.7.4 Saudi Arabia Metabolic Disease Drugs Market Size, 2017-2028
        6.7.5 UAE Metabolic Disease Drugs Market Size, 2017-2028
7 Players Profiles
    7.1 Merck
        7.1.1 Merck Corporate Summary
        7.1.2 Merck Business Overview
        7.1.3 Merck Metabolic Disease Drugs Major Product Offerings
        7.1.4 Merck Metabolic Disease Drugs Revenue in Global Market (2017-2022)
        7.1.5 Merck Key News
    7.2 Novartis
        7.2.1 Novartis Corporate Summary
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Metabolic Disease Drugs Major Product Offerings
        7.2.4 Novartis Metabolic Disease Drugs Revenue in Global Market (2017-2022)
        7.2.5 Novartis Key News
    7.3 Takeda Pharmaceutical
        7.3.1 Takeda Pharmaceutical Corporate Summary
        7.3.2 Takeda Pharmaceutical Business Overview
        7.3.3 Takeda Pharmaceutical Metabolic Disease Drugs Major Product Offerings
        7.3.4 Takeda Pharmaceutical Metabolic Disease Drugs Revenue in Global Market (2017-2022)
        7.3.5 Takeda Pharmaceutical Key News
    7.4 Astra Zeneca
        7.4.1 Astra Zeneca Corporate Summary
        7.4.2 Astra Zeneca Business Overview
        7.4.3 Astra Zeneca Metabolic Disease Drugs Major Product Offerings
        7.4.4 Astra Zeneca Metabolic Disease Drugs Revenue in Global Market (2017-2022)
        7.4.5 Astra Zeneca Key News
    7.5 Beohrigher Ingelheim
        7.5.1 Beohrigher Ingelheim Corporate Summary
        7.5.2 Beohrigher Ingelheim Business Overview
        7.5.3 Beohrigher Ingelheim Metabolic Disease Drugs Major Product Offerings
        7.5.4 Beohrigher Ingelheim Metabolic Disease Drugs Revenue in Global Market (2017-2022)
        7.5.5 Beohrigher Ingelheim Key News
    7.6 KOWA
        7.6.1 KOWA Corporate Summary
        7.6.2 KOWA Business Overview
        7.6.3 KOWA Metabolic Disease Drugs Major Product Offerings
        7.6.4 KOWA Metabolic Disease Drugs Revenue in Global Market (2017-2022)
        7.6.5 KOWA Key News
    7.7 Kythera
        7.7.1 Kythera Corporate Summary
        7.7.2 Kythera Business Overview
        7.7.3 Kythera Metabolic Disease Drugs Major Product Offerings
        7.7.4 Kythera Metabolic Disease Drugs Revenue in Global Market (2017-2022)
        7.7.5 Kythera Key News
    7.8 Fuji yakuhin
        7.8.1 Fuji yakuhin Corporate Summary
        7.8.2 Fuji yakuhin Business Overview
        7.8.3 Fuji yakuhin Metabolic Disease Drugs Major Product Offerings
        7.8.4 Fuji yakuhin Metabolic Disease Drugs Revenue in Global Market (2017-2022)
        7.8.5 Fuji yakuhin Key News
    7.9 LG Life Science
        7.9.1 LG Life Science Corporate Summary
        7.9.2 LG Life Science Business Overview
        7.9.3 LG Life Science Metabolic Disease Drugs Major Product Offerings
        7.9.4 LG Life Science Metabolic Disease Drugs Revenue in Global Market (2017-2022)
        7.9.5 LG Life Science Key News
    7.10 Metsubishi Tanabe Pharma
        7.10.1 Metsubishi Tanabe Pharma Corporate Summary
        7.10.2 Metsubishi Tanabe Pharma Business Overview
        7.10.3 Metsubishi Tanabe Pharma Metabolic Disease Drugs Major Product Offerings
        7.10.4 Metsubishi Tanabe Pharma Metabolic Disease Drugs Revenue in Global Market (2017-2022)
        7.10.5 Metsubishi Tanabe Pharma Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Metabolic Disease Drugs Market Opportunities & Trends in Global Market
    Table 2. Metabolic Disease Drugs Market Drivers in Global Market
    Table 3. Metabolic Disease Drugs Market Restraints in Global Market
    Table 4. Key Players of Metabolic Disease Drugs in Global Market
    Table 5. Top Metabolic Disease Drugs Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Metabolic Disease Drugs Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Metabolic Disease Drugs Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Metabolic Disease Drugs Product Type
    Table 9. List of Global Tier 1 Metabolic Disease Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Metabolic Disease Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Metabolic Disease Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Metabolic Disease Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Metabolic Disease Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Metabolic Disease Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Metabolic Disease Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Metabolic Disease Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Metabolic Disease Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Metabolic Disease Drugs Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Metabolic Disease Drugs Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Metabolic Disease Drugs Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Metabolic Disease Drugs Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Metabolic Disease Drugs Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Metabolic Disease Drugs Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Metabolic Disease Drugs Revenue, (US$, Mn), 2023-2028
    Table 30. Merck Corporate Summary
    Table 31. Merck Metabolic Disease Drugs Product Offerings
    Table 32. Merck Metabolic Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 33. Novartis Corporate Summary
    Table 34. Novartis Metabolic Disease Drugs Product Offerings
    Table 35. Novartis Metabolic Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 36. Takeda Pharmaceutical Corporate Summary
    Table 37. Takeda Pharmaceutical Metabolic Disease Drugs Product Offerings
    Table 38. Takeda Pharmaceutical Metabolic Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 39. Astra Zeneca Corporate Summary
    Table 40. Astra Zeneca Metabolic Disease Drugs Product Offerings
    Table 41. Astra Zeneca Metabolic Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 42. Beohrigher Ingelheim Corporate Summary
    Table 43. Beohrigher Ingelheim Metabolic Disease Drugs Product Offerings
    Table 44. Beohrigher Ingelheim Metabolic Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 45. KOWA Corporate Summary
    Table 46. KOWA Metabolic Disease Drugs Product Offerings
    Table 47. KOWA Metabolic Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 48. Kythera Corporate Summary
    Table 49. Kythera Metabolic Disease Drugs Product Offerings
    Table 50. Kythera Metabolic Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 51. Fuji yakuhin Corporate Summary
    Table 52. Fuji yakuhin Metabolic Disease Drugs Product Offerings
    Table 53. Fuji yakuhin Metabolic Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 54. LG Life Science Corporate Summary
    Table 55. LG Life Science Metabolic Disease Drugs Product Offerings
    Table 56. LG Life Science Metabolic Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 57. Metsubishi Tanabe Pharma Corporate Summary
    Table 58. Metsubishi Tanabe Pharma Metabolic Disease Drugs Product Offerings
    Table 59. Metsubishi Tanabe Pharma Metabolic Disease Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Metabolic Disease Drugs Segment by Type in 2021
    Figure 2. Metabolic Disease Drugs Segment by Application in 2021
    Figure 3. Global Metabolic Disease Drugs Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Metabolic Disease Drugs Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Metabolic Disease Drugs Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Metabolic Disease Drugs Revenue in 2021
    Figure 8. By Type - Global Metabolic Disease Drugs Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Metabolic Disease Drugs Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Metabolic Disease Drugs Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Metabolic Disease Drugs Revenue Market Share, 2017-2028
    Figure 12. US Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Metabolic Disease Drugs Revenue Market Share, 2017-2028
    Figure 16. Germany Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 17. France Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Metabolic Disease Drugs Revenue Market Share, 2017-2028
    Figure 24. China Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 28. India Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Metabolic Disease Drugs Revenue Market Share, 2017-2028
    Figure 30. Brazil Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Metabolic Disease Drugs Revenue Market Share, 2017-2028
    Figure 33. Turkey Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Metabolic Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 37. Merck Metabolic Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Novartis Metabolic Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Takeda Pharmaceutical Metabolic Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Astra Zeneca Metabolic Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Beohrigher Ingelheim Metabolic Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. KOWA Metabolic Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Kythera Metabolic Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Fuji yakuhin Metabolic Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. LG Life Science Metabolic Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Metsubishi Tanabe Pharma Metabolic Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
63
Frequently Asked Questions
Metabolic Disease Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Metabolic Disease Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Metabolic Disease Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports